November 4, 2011 (Tayside, Scotland) — With growing excitement over the emergence of transcatheter aortic-valve implantation (TAVI), might there still be room for an even less invasive option in ...

In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...

kidney Risk of mortality in HF patients with reduced kidney function taking ACE inhibitors and ARBs were evaluated. WASHINGTON, DC—According to data presented at the ACC.17 Scientific Session, ...

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...

Although current guidelines recommend that ACE inhibitors and angiotensin-receptor blockers (ARBs) be used in high doses in patients with congestive heart failure, many CHF patients currently receive ...

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments. PHILADELPHIA — Angiotensin-converting enzyme (ACE) inhibitors and ...

April 23, 2012 (Updated April 26, 2012) (Rotterdam, the Netherlands) — A new meta-analysis has shown that use of ACE inhibitors is associated with a 10% reduction in all-cause mortality over four ...

Do ACE inhibitors or angiotensin II receptor blockers (ARBs) offer renal protection to patients with diabetes or renal disease?— Negeen Farmand, PA-C, Los Angeles When should a clinician stop an ACE ...

The European Medicines Agency (EMA) has issued a statement reiterating that people should continue to take certain blood pressure medicines during the COVID-19 pandemic. Recent observational studies, ...

A new opinion piece published in the journal Circulation Research in April 2020 defends the use of antihypertensive drugs called ACE inhibitors and ARBs in patients with pandemic viral pneumonia ...

The use of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in people with congestive heart failure (CHF) and renal dysfunction is poorly studied. Berger and ...

PHILADELPHIA – Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) may represent effective migraine prophylactic treatments, according to the results of a ...